Company Research Report: Triumph Research Intelligence Limited

Company Overview

Name: Triumph Research Intelligence Limited (TRI)

Mission: Simplifying Risk-Based Quality Management (RBQM) for clinical trials through innovative platforms to enhance trial efficiency, safety, and compliance.

Founded: 2013

Founders: No information is available

Key People:

• Duncan Hall, CEO

• Gemma Telfer, VP, Marketing

Headquarters: 1 Signet Court, Swann's Road, Cambridge, CB5 8LA, UK

Number of Employees: No information is available

Revenue: No information is available

Known For:
TRI is renowned for its RBQM software solutions that improve quality and efficiency in clinical trials. Their platforms, such as OPRA-CM for centralized monitoring and OPRA-RAM for advanced risk management, are pivotal in transforming research methodologies with smart technology.

Products Offered

1. OPRA-CM

• Description: Centralized monitoring platform launched in 2016.

• Key Features:

• Proactively identifies and addresses trial risks before they occur.

• Provides a holistic risk assessment, considering every trial phase from protocol design to data analysis.

• Relies on data analytics for informed decision-making in risk mitigation.

• Adapts flexibly to changes and unforeseen circumstances.

• Offers transparency through documented risk assessments and decision-making processes.

2. OPRA-RAM

• Description: Advanced risk assessment and management tool introduced in 2020.

• Key Features:

• Empowers researchers to proactively identify, evaluate, and mitigate risks.

• Ensures integrity and reliability of research outcomes.

• Sets new benchmarks in research risk management.

Recent Developments

New Products & Features

• Integration with Veeva Product Partner Program (October 17, 2024):

• TRI has integrated its OPRA RBQM platform with Veeva Vault EDC. This integration streamlines data capture and monitoring for clinical trials, reducing costs, ensuring safety, and maintaining regulatory compliance.

• The partnership empowers clinical trial sponsors and CROs to leverage OPRA’s insights for effective management of critical data.

New Partnerships

• Collaboration with Veeva:

TRI became an official partner in Veeva’s Product Partner Program to enhance their risk-based quality management integration.

Industry Participation

• SCDM 2024 Participation (October 11, 2024):

At the Society for Clinical Data Management (SCDM) annual conference, TRI's leadership in Risk-Based Clinical Data Management was highlighted, showcasing advancements in how AI and RBQM frameworks drive industry standards.

Conclusion

Triumph Research Intelligence Limited is a leading company in advancing risk-based quality management for clinical trials. With its headquarters in Cambridge, UK, TRI continues to innovate with platforms like OPRA-CM and OPRA-RAM, contributing significantly to clinical trial quality, efficiency, and compliance. Through partnerships and industry engagement, TRI remains at the forefront of transforming clinical data management practices.